Zang, Aimin
105  results:
Search for persons X
?
2

Patient-reported outcomes for the phase 3 FURLONG study of ..:

Shi, Yuankai ; Chen, Gongyan ; Wang, Xiang...
The Lancet Regional Health - Western Pacific.  48 (2024)  - p. 101122 , 2024
 
?
6

A pooled analysis of clinical outcome in driver-gene negati..:

Yu, Yongfeng ; Dong, Wen ; Shi, Yanxia...
Therapeutic Advances in Medical Oncology.  16 (2024)  - p. , 2024
 
?
 
?
11

Elevation of microRNA-365 impedes malignant behaviors of ga..:

Hong, Dan ; Zang, Aimin ; Wang, Zhiyu...
Functional & Integrative Genomics.  22 (2022)  5 - p. 825-834 , 2022
 
?
12

Central Nervous System Efficacy of Furmonertinib (AST2818) ..:

Shi, Yuankai ; Chen, Gongyan ; Wang, Xiang...
Journal of Thoracic Oncology.  17 (2022)  11 - p. 1297-1305 , 2022
 
?
13

Efficacy and Safety of Limertinib (ASK120067) in Patients W..:

Shi, Yuankai ; Li, Baolan ; Wu, Lin...
Journal of Thoracic Oncology.  17 (2022)  10 - p. 1205-1215 , 2022
 
?
 
?
15

Efficacy and safety of GLS-010 (zimberelimab) in patients w..:

Lin, Ningjing ; Zhang, Mingzhi ; Bai, Hai...
European Journal of Cancer.  164 (2022)  - p. 117-126 , 2022
 
1-15